For disclosure purposes I bought ETRM when it was $ 1.14 per share, have not sold one single share and my target price is $ 12 per share within 6 months at most.
This is why I bought. In February 2013 stock plunged from $ 4 to $ 1 per share when 12 month data did not hit endpoints but did show efficacy and safety plus diebetic and hypertension benefits. I saw there was an opportunity to load up but need reassurances before going forward. In May 2013 ETRM met FDA to discuss their clinical results wanting to know if they were good enough for a PMA filing or not. FDA encouraged ETRM to file PMA. At this point I had not bought either since it could just be company talk. In June 2013 PMA was filed and within 1 month FDA accepted filing. This provided reassurance that encouragement from FDA was real.
At that point I loaded up on the stock at $ 1.14. The FDA then sent a letter to ETRM which asked for information post approval which to me confirmed a friendly FDA with ETRM. Also FDA requested 18 month data to beef up the file. ETRM showed results first to FDA to get their blessing before releasing to the public.
In the meantime FDA guidelines have changed to approve obesity pills or device if they show efficacy and safety over risk and, not focused on endpoints. This is all great news. Now FDA is guiding ETRM towards FDA Panel of doctors, again another reassuring sign.
Why is FDA cooperating because of OBAMACARE and need to bring down $ 147 billion per year in healthcare costs. Plus 1st lady put curing obesity on a priority list.
In terms of VBLOC market potential. 1/3 of the USA is obese ( 100 million people) would qualify for VBLOC. People are afraid to take pills due to side effects and only 200,000 people staple their stomachs, again rate is low due to safety concerns. This leaves a market of 100 million people to VBLOC as alternative safe choice. 100,000 people at $ 10K per device gives $ 1 billion in sales, $ 2.13/share.
The news releases means that the JOINT VENTURE (Kandi and Geely 50/50) will pay $ 104 million to Shanghai to get the electrical vehicle division of Shanghai under the joint venture. This was done to enchance and make easier R&D on EV.
All the EV are coming under ONE ROOF for Geely and Kandi, which means a solid long term relationship is being cemented further. It also means expansion to Shanghai and, also part of cab deal for England.
Geely being a $ 50 billion company is giving lots of strength and credibility to Kandi as it enforces its partnership.
With time, I envision that Geely may buy out Kandi altogether, which is not out of the question. What is a few billion dollars if Geely gets to control everything in China.
I don't if your questions relates to price target or buyout. However I believe we will hit both this year so $ 12 per share is my target price and possible buyout too. Obesity market is a multi billion market per year and so far no one has succeeded not diet pills nor stomach staples so the door is wide open to something in between which is VBLOC.
My son lost 80 pounds on his own by controlling his hunger, something VBLOC does. Not everyone has my son's determination. He is young and can do it, I am too old and would need VBLOC.
If you gave me a choice of diet pills, stomach staple or VBLOC, I would choose VBLOC due to SAFETY which is my biggest concern as I don't have to alter my lifestyle too much and yet go from being obese to say non-obese over time.
I would suggest you LOAD UP before we really begin to RALLY. This is only a small taste of things to come, the best of the cake is forthcoming.
The only sector of the market I have truly made an enormous amount of money is in the biotech.
I have noted a tendency in these biotech's. I can name quite a few stocks but there is DNDN, RMTI, KERX, JAZZ and others. It works as follows. The shark investor in this field and I am speaking of almost criminal activity will find a biotech stock which should have material changes and face easy approval with FDA. Based on this they plunge the stock and shake out the small investor while they load up in the millions of shares. When approval comes, stock soars beyond all limits and they rake it in. The poor small investor gets to watch what was stolen from him.
The fundamentals in ETRM have not changed. There will be MATERIAL EVENT which will propel ETRM into the billion dollar obesity market with force and, minimal sales will result in ROBUST earnings. The sharks know approval is in the bag and shake the tree to get you to sell. This stock should have a valuation of $ 400 million to $ 1.4 billion and, not a measily $ 110 million which is a STEAL.
In terms of price, it should be $ 12 per share at the very minimum.
You have a choice, either you live in fear and sell out to the shark or, have some confidence in yourself and load up as the sharks are doing themselves. You will be rewarded, I am certain of this. I have seen this too many times. When price hits my target, you will regret it if you sold.
This is the nature of the biotech and shark will prey on your impatience by creating fear.
PS: I have not sold one share. I purchased at $ 1.14 and am staying put. Probably will sell at $ 12 per share.
KNDI is going to have to work OVERTIME to reach this number. Subsidies extended beyond 2015, probably until 2020 as CHINA says they are way behind schedule on the 20 million EV cars.
KNDI short term $ 40 per share based on this info alone.
Watch it EXPLODE....
We are trading at $ 1.94 because VBLOC is not approved. What will it trade if APPROVED.
You said 10 times that amount, so I guess $ 19.40.
You can buy a blue chip stock like Apple feeling secure and in 3 years they become a Blackberry.
Let me tell of the others I found which like you say was risk and could be worthless:
a) CSIQ found it at $ 3.75, went to $ 43
b) RMTI found it at $ 3.75, went to $ 15
c) KERX found it at $ 3.5, went to $ 15
d) Jazz found it at $ 10, went to $ 150
e) DNDN found it at $ 3.50 went to $ 50
f) Google found it at $ 103, went to $ 1,100
g) Gorro Gold found it at $ 4 went to $ 28
The list I have found goes on and on and on like this.
I don't know why but investors are too risk averse, impatient, afraid and non-confident. They miss huge opportunities by going on emotion and not hard research.
Obesity in the USA is an epidemic. The USA is broke and needs to bring healthcare costs down. The USA spends $ 147 billion per year treating fat people diseases. Doctors are not prescribing diet pills due to severe side effects and, stomach staples is shunned by people due to drastic change in life and side effects.
HENCE A HUGE VOID TO FILL. VBLOC is safe, has diebetic and hypertension benefits which are two big illnesses. It does bring weight down and keeps it off without severely altering a persons life plus it benefits OBAMA by reducing costs.
SO WHERE IS THE RISK? The only risk I see is missing out as we hit your ten times estimate.
I remember a person who was in the same situation as you. He sold his stock for $ 80K profit to buy a nice expense car which depreciated over time.
In the meantime he watched his investment which he sold grow to $ 3.3 million. Of course he had sold and got to keep his car.
You are young so Kandi should not be sold for the next 5 years, it is in a HIGH GROWTH sector of the market in China with 1.2 billion people. They will be valued at $ 500 to $ 1000 in 5 years.
In March or April 2013 of this year I invested in CSIQ (Canadian Solar) at $ 3.75. I saw what others did not a parabolic rise in price in 2nd half of 2013. I sold at about $ 8 per share. The reason I did was that there was some dummy the equivalent of oozhe22 or penny_dreaddul that created some momentary doubt. The stock soared 1000% in 6 months to $ 33. Did I feel stupid listening to that paid basher on CSIQ.
In June of 2013 I invested a large chunk in RMTI (medical company) at $ 3.75 as I saw a parabolic rise in that one too. The stock rallied to $ 5.75 quickly then gave up a little and at $ 5 I sold. Again another dummy on that board telling me RMTI was fraud, clinical results were no good, no approval putting doubt in me. The stock went on to rally to $ 16 per share a 400% return in less than 6 months.
When it comes to stocks I know how to pick them except on occasion I lack the courage to hold to the end. This time I put a stop to it. I bought ETRM at $ 1.14 per share and although rally to $ 2.25 was a great return I told myself is no where near the parabolic rise I see in this to $ 12 per share or 1200% return.
What makes me bullish is that VBLOC will fill a void in the market. 33% of USA citizens are obese or about $ 100 million people. These people have 2 choices to date. Dangerous diet pills with serious side effects or staple your stomach again with serious side effects. VBLOC fills this void, it has a great safety record and provides additional benefits for diebetic and hypertension plus it results in long term EWL of 25% to 30% versus 0% if nothing is done.
In terms of revenue and profit. The device will retail for $ 10,000 and surgery $ 10,000. OBAMACARE requires insurers to cover obesity, it is the LAW. All it takes is 100,000 patients per year and we have $ 1 billion in sales and $ 2.13 per share in profit. 100,000 patients in peanuts when market is 100 million people.
So LOAD UP before others wake up.
I think we are finally starting to find out his TRUE MOTIVE. I believe he invested in ETRM when it was at his peak of $ 29 with family and friends. The stock plunged and he most probably got divorced due to this and his kids do not talk to him. Therefore he carries a baggage of anger with him and is determined to get his revenge to make anyone feel the hurt he does on ETRM. This is his TRUE MOTIVE. Notice how one mentions the family and he freaks out. It brings up bad memories.
Oozhe22, I am sorry if you lost your savings, marriage and kids because of a bad investment at that time however, making others pay for it will not help you heal.
Try forgiving, praying and doing some good to move on.
StockTwits is a social media platform designed for sharing ideas between investors, traders, and
entrepreneurs. The company was co-founded by Howard Lindzon and Soren Macbeth in 2009. The company received the first annual Shorty Award in the 2008 finance category. Time magazine listed the company as one of their 2010 "50 best websites". The company was also named one of the "top 10 most innovative companies in finance" in 2012 by FastCompany. As of June 2013 StockTwits currently has 230,000 active members.
StockTwits just came out with a report to its 230,000 Investors that ETRM is one Stock to want to bring substantial returns. If each investor puts a little money in, we are at $ 12 per share within a week, especially since we only have 35 million shares in circulation and, VBLOC will most likely generate between $ 250 million and $ 1 billion in revenue per year in OBESITY market and huge earnings per share.
There is a VOID to fill between diet pills and stomach staple surgery.
Market cap valuation as of today is $ 120 million with about 35 million shares as free float, the rest is in strong hands.
The rise has to do with investors beginning to understand the revenue and profit numbers for VBLOC going forward versus the present stock price plus speculation of either Fed Panel date or, news from FDA that no panel in required for approval.
If we get 25,000 patients per year as a start out of 100 million obese Americans we will have $ 250,000,000 in revenue, $ 50 million in profit and earnings of ,83 cents per share.
I believe VBLOC will easily hit these numbers as there are 20 million patients whom qualify for staple surgery and only 200,000 go for this procedure due to fear. This leaves 19.8 million people looking for a new option, and that VOID will be filled by VBLOC.
Very bullish close.
It also helps that investors now understand that oozhe22 or penny_dreaddful was a disgruntled investor of ETRM whom had purchased stock at its highs and, lost divorce plus kids and family in the process. His motive was to hurt other investors to make them feel his pain. I am certain his analysis had concerned a few whom believed him but now know the truth. Notice he has disappeared since I caught him in his lies.
Very possible for company with huge growth in next few quarters. Still cheap with $ 480 valuation compared to TESLA at $ 15 billion, so $ 2 billion is a fair estimate and not out of the question, which means $ 80 per share stock price.
The more due diligence I have done on VBLOC the more confident I become in its approval and, also more confident VBLOC will fill a significant VOID which exists in the market for obesity.
For starters OBESITY in the USA is an epidemic and only getting worse. It costs $ 147 billion per year to treat these people. In terms of people 33% of US is obese meaning 100 million people. Obamacare changed the focus on obesity, from now on insurance have to provide coverage and employers are forced to get employees to seek help or face higher premium costs. The government wants to get obesity to reasonable levels and is working with ETRM to get VBLOC approved.
The government approved diet pills with dangerous side effects to help however the doctors have blocked this adoption not pushing it to patients. Patients are fearful so diet pills are not working.
Patients were given an option with stomach staple. There are 20 million patients whom qualify per year and yet only 300,000 do surgery. The hold back: serious side effects.
People want to lose weight in a reasonable manner, which means no serious diet changes that will be forced by stomach staples or diet pills where you lose weight and die of a heart attack.
This opens the door to VBLOC. It is safe, has diebetic and hypertension benefits. You don't have to alter your life style in terms of eating habits, it is device which controls hunger. You can remove VBLOC any time you want and it is not too invasive in terms of surgery, recovery quickly with lots of hope for weight loss. The long term effects show that even at 30 months patients are maintaining serious weight loss.
In terms of market potential, each device retails for $ 10,000 with $ 10,000 for hospital stay. If VBLOC gets a reason amount of just the stomach staple crowd say 50,000 patients per year, revenues will be $ 500 million and earnings $ 1.67/share.
ETRM will be bought out as market is huge. Double digits soon enough.
I was unaware he was the lead investigator. This bodes very well for ETRM. If VBLOC replaces Bariatric surgery, it means 300,000 patients per year at $ 10,000 per device, so revenue of $ 3 billion per year.
People are really in a coma when it comes to ETRM. It trades at $ 140 million market cap, that if approved will generate $ 3 billion in sales.
Wow, just wow, lucky me to know this.
My target price of $ 12 per share has just become ultra conservative.
I was taking a shower this morning when I was filled with an instinct, can't explain, that there will announcement of FDA Panel date shortly. We will see if this feeling is correct.
Trading price will be $ 3.25 to $ 3.50, new high based on volume of about 20 million shares.
Lets see, it is just an instinct, I could be wrong,
If we look at a glass of water, one will say it is half empty, the other half full.
What is my point?
Despite all the negative talk with bariatric surgery there are still 300,000 people who have this surgery each year. These people do not have an alternative since pills is not an option. The negative press will actually benefit VBLOC as it gives doctors a chance to offer an alternative to their patients for this surgery.
Any prudent surgery will opt for a safer and less invasive procedure than that which is offered by stomach staple. VBLOC is the answer to this.
ETRM was contemplating hiring 100 sales people to spread the word to all doctors in this field. We don't need millions of patients to be extremely profitable. If we manage to replace stomach surgery, ETRM will make $ 3 billion per year.
Being realistic that we will not end up with this amount simply getting say 10% of this crowd or 30,000 people is $ 300 million in sales or 2x the present market cap.
I find ETRM is extremely cheap at these levels given the tremendous opportunity before them. Don't forget that VBLOC will be expanded to hypertension and diabetic.
What it comes down to is this, VBLOC properly marketed to the right crowd will return huge profits.
Big pharma has big funds and will see this so I think it gets BOUGHT OUT shortly after approval.